FDA Approves Neurotech Company for Testing Brain Chip in Humans

 

Activist Post reports that brain-computer interface, or BCI, represents the latest frontier of artificial intelligence and biology. While this technology is still early in development, a growing number of companies are already looking at its commercial applications.

On July 28, one of those companies, New York startup Synchron, received FDA approval to test its brain device in human patients. Stentrode, Synchron’s implantable device is small enough to be implanted via a blood vessel at the base of the neck. The device is then maneuvered toward a vessel in the brain.

Stentrode works by communicating through a tiny wire with a second implant in the chest. A transmitter then sends signals to an external computer near the patient.

“We have worked together to pave a pathway forward, towards the first commercial approval for a permanently implanted BCI for the treatment of paralysis”, Thomas Oxley, Synchron CEO, said via Activist Post.

The company plans to enroll six patients in its U.S. trial later this year. According to Oxley, the U.S. study will take a closer look at safety issues, including physical risks and cybersecurity. Activist Post reports an FDA-approved product could be on the market in as soon as 3 to 5 years.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

medicine
The Art of Recovery: Where Music and Medicine Meet in Patient Care
May 14, 2026

Healthcare today can feel overwhelming—not just for patients, but for the teams caring for them. After a major illness or injury, recovery isn’t handled by one doctor alone; it often involves a whole network of specialists, from physical therapists to nurses to social workers, all trying to help someone regain their independence and quality…

Read More
infant health
From Monitoring to Knowing: How Owlet Is Redefining Infant Health at Retail
May 14, 2026

Baby monitors have long promised parents the ability to see and hear their child from another room. But as connected health devices become more normalized in everyday life, from smartwatches to sleep trackers, parents are beginning to expect more than visibility. They want insight. For Owlet, that shift matters because its wearable monitors track…

Read More
SPD
Unlocking CensisAI²: The Metrics That Matter for Smarter SPD Decisions
May 13, 2026

Sterile processing departments are swimming in data, from workflow automation and supply data to patient outcome and quality metrics. But the real challenge is not collecting more information; it is knowing which metrics actually improve SPD performance, technician education, OR readiness and patient safety. For Censis, a leader in surgical asset management, the focus…

Read More
User-generated content
The New Rules of Discoverability: How User-Generated Content Is Reshaping Search, Trust, and Brand Visibility
May 12, 2026

User-generated content (UGC) is moving from marketing side dish to main course as large language models change how people discover brands, products, creators, and ideas. Customer reviews, forum posts, videos, and community conversations increasingly carry more influence than polished brand copy because they feel more specific, lived-in, and trustworthy. As AI systems learn from…

Read More